Similar articles

• The incidence of the acetylator phenotype of isoniazid in healthy and in pulmonary tuberculosis subjects in Bihar.

  Sinha CP, Sinha S, Sinha KP. Sinha CP, et al. J Assoc Physicians India. 1978 May;26(5):353-60. J Assoc Physicians India. 1978. PMID: 730714 No abstract available.
• [Incidence of hepatic changes in relation to the isoniazid acetylator phenotype].

  Pilheu JA, De Salvo MC, Manchinu I, de Negroni NR, Szemzo J. Pilheu JA, et al. Medicina (B Aires). 1980 Jul-Aug;40(4):382-6. Medicina (B Aires). 1980. PMID: 7207170 Spanish. No abstract available.
• Acetylator phenotyping with sulphadimidine in patients receiving isoniazid.

  Ylitalo P, Auterinen L, Marttinen A, Koivula T. Ylitalo P, et al. Int J Clin Pharmacol Res. 1984;4(2):141-4. Int J Clin Pharmacol Res. 1984. PMID: 6469440
• The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis.

  Ellard GA. Ellard GA. Tubercle. 1984 Sep;65(3):211-27. doi: 10.1016/0041-3879(84)90079-5. Tubercle. 1984. PMID: 6385429 Review. No abstract available.
• [Clinical pharmacology of isoniazid (a review of the literature)].

  Ivleva AIa. Ivleva AIa. Probl Tuberk. 1979 Jan;(1):18-26. Probl Tuberk. 1979. PMID: 368763 Review. Russian. No abstract available.